UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 7, 2026
Sale
Calculated transaction value
$432.95K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 6, 2026
Public filing date
Aug 7, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$532.94
Aug 6, 2026
Close before public filing
$532.94
Aug 6, 2026
Return since public filing
-6.72%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 824 shares @ $525.42
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000115
Filing cohort
Transactions in this filing
Showing 15 of 20
Trades
20
Issuers
1
Estimated value
$6.28M
Buys / sales
0 / 18
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Aug 6, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $41K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $321.83K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $135.76K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $62.01K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $41.43K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $41.53K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $329.66K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $375.05K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $62.74K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $95.41K |
| United Therapeutics Corp UTHR Current | Sale | Aug 6, 2026 | $432.95K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $714.22K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $676.42K |
| United Therapeutics Corp UTHR | Sale | Aug 6, 2026 | $462.25K |